BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6084289)

  • 21. Molecular genetics of the HLA system.
    Bodmer WF; Carey J; Jenkins J; Lee J; Trowsdale J
    Princess Takamatsu Symp; 1982; 12():307-20. PubMed ID: 6187727
    [No Abstract]   [Full Text] [Related]  

  • 22. A human monoclonal antibody recognizing a determinant shared by a group of HLA-B locus antigens associated with HLA-Bw6.
    Kosinski S; Yang SY; Ferrara GB; Hämmerling U
    Immunogenetics; 1987; 26(1-2):120-2. PubMed ID: 2440801
    [No Abstract]   [Full Text] [Related]  

  • 23. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.
    Kahn-Perles B; Wietzerbin J; Caillol DH; Lemonnier F
    J Immunol; 1985 Mar; 134(3):1759-65. PubMed ID: 2578520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public determinants of HLA indicated by pregnancy antibodies.
    Konoeda Y; Terasaki PI; Wakisaka A; Park MS; Mickey MR
    Transplantation; 1986 Feb; 41(2):253-9. PubMed ID: 2418552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.
    Layet C; Delovitch T; Ferrier P; Caillol DH; Jordan BR; Lemonnier FA
    Immunogenetics; 1985; 21(5):469-78. PubMed ID: 2581891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules.
    Pellegrino MA; Ng AK; Russo C; Ferrone S
    Transplantation; 1982 Jul; 34(1):18-23. PubMed ID: 6181590
    [No Abstract]   [Full Text] [Related]  

  • 29. A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).
    Antonelli P; Choo SY; Nisperos B; Hansen JA
    Tissue Antigens; 1985 Aug; 26(2):114-20. PubMed ID: 2414860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
    Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
    Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polymorphic determinants of HLA-A, B molecules analysed with monoclonal antibodies: serologic characterization and evaluation of technical variations].
    Crepaldi T; Marsico D; Peruccio D; Richiardi P
    Riv Emoter Immunoematol; 1984; 31(1):36-48. PubMed ID: 6085186
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes.
    Nosek J; Hinzová E; Vorlíćek J
    Immunogenetics; 1987; 26(4-5):273-81. PubMed ID: 3477527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of HLA in IgA nephropathy.
    Kasahara M; Hamada K; Okuyama T; Ishikawa N; Ogasawara K; Ikeda H; Takenouchi T; Wakisaka A; Aizawa M; Kataoka Y; Miyamoto R; Kohara M; Naito S; Kashiwagi N; Hiki Y
    Clin Immunol Immunopathol; 1982 Nov; 25(2):189-95. PubMed ID: 6984672
    [No Abstract]   [Full Text] [Related]  

  • 35. [HLA antigens in choriocarcinoma].
    Sasagawa M; Suzuki T; Kajino T; Ohno M; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):81-4. PubMed ID: 6366090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of HLA antigens on blood platelets and lymphocytes by means of monoclonal antibodies in an ELISA technique.
    Lansdorp PM; Oosterhof F; Astaldi GC; Zeijlemaker WP
    Tissue Antigens; 1982 Jan; 19(1):11-9. PubMed ID: 6176045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
    El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
    Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class I epitopes: A and B loci.
    El-Awar N; Cook D; Terasaki PI
    Clin Transpl; 2006; ():79-94. PubMed ID: 18365370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The origins of HLA-A,B,C polymorphism.
    Parham P; Adams EJ; Arnett KL
    Immunol Rev; 1995 Feb; 143():141-80. PubMed ID: 7558075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.